Accès gratuit
Pré-publication électronique
Dans une revue
Ann. Fr. Med. Urgence
Section Mise au point / Update
DOI https://doi.org/10.3166/afmu-2019-0186
Publié en ligne 14 juillet 2020
  • Almagro P, Cabrera FJ, Diez J, et al (2012) Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest 142:1126–33 [PubMed] [Google Scholar]
  • Gale NS, Bolton CE, Duckers JM, et al (2012) Systemic comorbidities in bronchiectasis. Chron Respir Dis 9:231–8 [CrossRef] [PubMed] [Google Scholar]
  • Maclay JD, MacNee W (2013) Cardiovascular disease in COPD: mechanisms. Chest 143:798–807 [PubMed] [Google Scholar]
  • Vivodtzev I, Tamisier R, Baguet JP, et al (2014) Arterial stiffness in COPD. Chest 145:861–75 [PubMed] [Google Scholar]
  • Agusti A, Calverley PMA, Celli B, et al (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 11:122 [CrossRef] [PubMed] [Google Scholar]
  • Wang Y, Stavem K, Dahl FA, et al (2014) Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Int J Chron Obstruct Pulmon Dis 9:99–105 [CrossRef] [PubMed] [Google Scholar]
  • Perera PN, Armstrong EP, Sherrill DL, 2012) Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD 9:131–41 [CrossRef] [PubMed] [Google Scholar]
  • Wang Y, Stavem K, Dahl FA, et al (2014) Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Int J Chron Obstruct Pulmon Dis 9:99–105 [CrossRef] [PubMed] [Google Scholar]
  • Garcia-Aymerich J, Gómez FP, Benet M, et al (2011) Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 66:430–7 [CrossRef] [PubMed] [Google Scholar]
  • Burgel PR, Paillasseur JL, Peene B, et al (2012) Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality. PLoS ONE 7:e51048 [CrossRef] [PubMed] [Google Scholar]
  • Malerba M, Clini E, Malagola M, 2013) Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease. Expert Rev Hematol 6:475–83 [CrossRef] [PubMed] [Google Scholar]
  • Harrison MT, Short P, Williamson PA, et al (2014) Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy? Thorax 69:609–15 [CrossRef] [PubMed] [Google Scholar]
  • Macchia A, Rodriguez Moncalvo JJ, Kleinert M, et al (2012) Unrecognised ventricular dysfunction in COPD. Eur Respir J 39:51–8 [CrossRef] [PubMed] [Google Scholar]
  • Boudestein LCM, Rutten FH, Cramer MJ, et al (2009) The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail 11:1182–8 [CrossRef] [PubMed] [Google Scholar]
  • Huiart L, Ernst P, Suissa S (2005) Cardiovascular morbidity and mortality in COPD. Chest 128:2640–6 [PubMed] [Google Scholar]
  • Fuso L, Incalzi RA, Pistelli R, et al (1995) Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 98:272–7 [Google Scholar]
  • Høiseth AD, Omland T, Karlsson BD, et al (2013) Standardized evaluation of lung congestion during COPD exacerbation better identifies patients at risk of dying. Int J Chron Obstruct Pulmon Dis 8:621–9 [CrossRef] [PubMed] [Google Scholar]
  • Høiseth AD, Omland T, Hagve TA, et al (2012) NT-proBNP independently predicts long term mortality after acute exacerbation of COPD — a prospective cohort study. Respir Res 13:97 [CrossRef] [PubMed] [Google Scholar]
  • Kalhan R, Mutharasan RK (2018) Reducing readmissions in patients with both heart failure and COPD. Chest 154:1230–8 [PubMed] [Google Scholar]
  • Orea-Tejeda A, Navarrete-Peñaloza AG, Verdeja-Vendrell L, et al (2018) Right heart failure as a risk factor for severe exacerbation in patients with chronic obstructive pulmonary disease: prospective cohort study. Clin Respir J 12:2635–41 [CrossRef] [PubMed] [Google Scholar]
  • Baldwin ED, Cournand A, Richards DW (1949) Pulmonary insufficiency; a study of 122 cases of chronic pulmonary emphysema. Medicine 28:201–37 [CrossRef] [PubMed] [Google Scholar]
  • Neder JA, Rocha A, Alencar MCN, et al (2018) Current challenges in managing comorbid heart failure and COPD. Expert Rev Cardiovasc Ther 16:653–73 [Google Scholar]
  • Wells JM, Dransfield MT (2013) Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD. Int J Chron Obstruct Pulmon Dis 8:509–21 [CrossRef] [PubMed] [Google Scholar]
  • Thomson AJ, Drummond GB, Waring WS, et al (2006) Effects of short-term isocapnic hyperoxia and hypoxia on cardiovascular function. J Appl Physiol 101:809–16 [CrossRef] [PubMed] [Google Scholar]
  • Horodinschi RN, Bratu OG, Dediu GN, et al (2019) Heart failure and chronic obstructive pulmonary disease: a review. Acta Cardiol 16:1–8 [Google Scholar]
  • Schiavo A, Renis M, Polverino M, et al (2016) Acid-base balance, serum electrolytes and need for non-invasive ventilation in patients with hypercapnic acute exacerbation of chronic obstructive pulmonary disease admitted to an internal medicine ward. Multidiscip Respir Med 11:23 [CrossRef] [PubMed] [Google Scholar]
  • Terzano C, Di Stefano F, Conti V, et al (2012) Mixed acid-base disorders, hydroelectrolyte imbalance and lactate production in hypercapnic respiratory failure: the role of noninvasive ventilation. PLoS ONE 7:e35245 [CrossRef] [PubMed] [Google Scholar]
  • Halpin DMG, Decramer M, Celli B, et al (2011) Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT® trial. Lung 189:261–8 [Google Scholar]
  • Donaldson GC, Hurst JR, Smith CJ, et al (2010) Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 137:1091–7 [PubMed] [Google Scholar]
  • Portegies MLP, Lahousse L, Joos GF, et al (2016) Chronic obstructive pulmonary disease and the risk of stroke. The Rotterdam study. Am J Respir Crit Care Med 193:251–8 [CrossRef] [Google Scholar]
  • Rothnie KJ, Connell O, Müllerová H, et al (2018) Myocardial infarction and ischemic stroke after exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc 15:935–46 [Google Scholar]
  • Agusti A, Calverley PMA, Celli B, et al (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 11:122 [CrossRef] [PubMed] [Google Scholar]
  • Han MK, Agusti A, Calverley PM, et al (2010) Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 182:598–604 [CrossRef] [PubMed] [Google Scholar]
  • Burgel PR, Paillasseur JL, Caillaud D, et al (2010) Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 36:531–9 [CrossRef] [PubMed] [Google Scholar]
  • Rothnie KJ, Yan R, Smeeth L, 2015) Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open 5:e007824 [CrossRef] [PubMed] [Google Scholar]
  • Chang CL, Robinson SC, Mills GD, et al (2011) Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax 66:764–8 [CrossRef] [PubMed] [Google Scholar]
  • Høiseth AD, Neukamm A, Karlsson BD, et al (2011) Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease. Thorax 66:775–81 [CrossRef] [PubMed] [Google Scholar]
  • Baillard C, Boussarsar M, Fosse JP, et al (2003) Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 29:584–9 [CrossRef] [PubMed] [Google Scholar]
  • Pavasini R, d’Ascenzo F, Campo G, et al (2015) Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Cardiol 191:187–93 [CrossRef] [PubMed] [Google Scholar]
  • Polosa R, Malerba M, Cacciola RR, et al (2013) Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients. Intern Emerg Med 8:567–74 [CrossRef] [PubMed] [Google Scholar]
  • Sabit R, Thomas P, Shale DJ, et al (2010) The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD. Chest 138:47–51 [PubMed] [Google Scholar]
  • Corlateanu A, Covantev S, Mathioudakis AG, et al (2018) Chronic obstructive pulmonary disease and stroke. COPD 15:405–13 [CrossRef] [PubMed] [Google Scholar]
  • Brekke PH, Omland T, Smith P, Søyseth V (2008) Underdiagnosis of myocardial infarction in COPD — Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. Respir Med 102:1243–7 [CrossRef] [PubMed] [Google Scholar]
  • Pavasini R, Biscaglia S, d’Ascenzo F, et al (2016) Antiplatelet treatment reduces all-cause mortality in COPD patients: a systematic review and meta-analysis. COPD 13:509–14 [CrossRef] [PubMed] [Google Scholar]
  • Gunen H, Gulbas G, In E, et al (2010) Venous thromboemboli and exacerbations of COPD. Eur Respir J 35:1243–8 [CrossRef] [PubMed] [Google Scholar]
  • Aleva FE, Voets LWLM, Simons SO, et al (2017) Prevalence and localization of pulmonary embolism in unexplained acute exacerbations of COPD: a systematic review and meta-analysis. Chest 151:544–54 [PubMed] [Google Scholar]
  • Rizkallah J, Man SFP, Sin DD (2009) Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest 135:786–93 [PubMed] [Google Scholar]
  • Le Mao R, Tromeur C, Bazire A, et al (2017) Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study. Eur Respir J 50(1):1700094 [CrossRef] [PubMed] [Google Scholar]
  • Carson JL, Terrin ML, Duff A, 1996) Pulmonary embolism and mortality in patients with COPD. Chest 110:1212–9 [PubMed] [Google Scholar]
  • Bertoletti L, Quenet S, Mismetti P, et al (2012) Clinical presentation and outcome of venous thromboembolism in COPD. Eur Respir J 39:862–8 [CrossRef] [PubMed] [Google Scholar]
  • Bertoletti L, Quenet S, Laporte S, et al (2013) Pulmonary embolism and 3-month outcomes in 4,036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry. Respir Res 14:75 [CrossRef] [PubMed] [Google Scholar]
  • Malerba M, Nardin M, Radaeli A, et al (2017) The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients. Expert Rev Hematol 10:821–32 [CrossRef] [PubMed] [Google Scholar]
  • Sabit R, Thomas P, Shale DJ, et al (2010) The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD. Chest 138:47–51 [PubMed] [Google Scholar]
  • Undas A, Jankowski M, Kaczmarek P, et al (2011) Thrombin generation in chronic obstructive pulmonary disease: dependence on plasma factor composition. Thromb Res 128:e24–e8 [Google Scholar]
  • Akpinar EE, Hoşgün D, Doğanay B, et al (2013) Should the cutoff value of D-dimer be elevated to exclude pulmonary embolism in acute exacerbation of COPD? J Thorac Dis 5:430–4 [PubMed] [Google Scholar]
  • Shi X, Li H (2013) Anticoagulation therapy in patients with chronic obstructive pulmonary disease in the acute exacerbation stage. Exp Ther Med 5:1367–70 [CrossRef] [PubMed] [Google Scholar]
  • Andersson C, Hansen PW, Steffensen IE, et al (2019) Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure — a danish nationwide registry-based study. Eur J Intern Med 63:56–61 [CrossRef] [PubMed] [Google Scholar]
  • Incalzi RA, Corsonello A, Pedone C, et al (2010) Chronic renal failure: a neglected comorbidity of COPD. Chest 137:831–7 [PubMed] [Google Scholar]
  • Gjerde B, Bakke PS, Ueland T, et al (2012) The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway. Respir Med 106:361–6 [CrossRef] [PubMed] [Google Scholar]
  • Terzano C, Colamesta V, Unim B, et al (2017) Chronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalization. Eur Rev Med Pharmacol Sci 21:3680–9 [PubMed] [Google Scholar]
  • Singanayagam A, Schembri S, Chalmers JD (2013) Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 10:81–9 [Google Scholar]
  • Fedeli U, De Giorgi A, Gennaro N, et al (2017) Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy. Int J Chron Obstruct Pulmon Dis 12:443–50 [CrossRef] [PubMed] [Google Scholar]
  • Barakat MF, McDonald HI, Collier TJ, et al (2015) Acute kidney injury in stable COPD and at exacerbation. Int J Chron Obstruct Pulmon Dis 10:2067–77 [CrossRef] [PubMed] [Google Scholar]
  • Cao CC, Chen DW, Li J, et al (2018) Community-acquired versus hospital-acquired acute kidney injury in patients with acute exacerbation of COPD requiring hospitalization in China. Int J Chron Obstruct Pulmon Dis 13:2183–90 [CrossRef] [PubMed] [Google Scholar]
  • HajGhanbari B, Holsti L, Road JD, Darlene Reid W (2012) Pain in people with chronic obstructive pulmonary disease (COPD). Respir Med 106:998–1005 [CrossRef] [PubMed] [Google Scholar]
  • HajGhanbari B, Garland SJ, Road JD, 2013) Pain and physical performance in people with COPD. Respir Med 107:1692–9 [CrossRef] [PubMed] [Google Scholar]
  • Bentsen SB, Rustøen T, Miaskowski C (2011) Prevalence and characteristics of pain in patients with chronic obstructive pulmonary disease compared to the Norwegian general population. J Pain 12:539–45 [Google Scholar]
  • van Dam van Isselt EF, Groenewegen-Sipkema KH, Spruitvan Eijk M, et al (2014) Pain in patients with COPD: a systematic review and meta-analysis. BMJ Open 4:e005898 [CrossRef] [PubMed] [Google Scholar]
  • Borge CR, Wahl AK, Moum T (2011) Pain and quality of life with chronic obstructive pulmonary disease. Heart Lung 40: e90–e101 [CrossRef] [PubMed] [Google Scholar]
  • Lee AL, Harrison SL, Goldstein RS, 2018) An exploration of pain experiences and their meaning in people with chronic obstructive pulmonary disease. Physiother Theory Pract 34:765−72 [Google Scholar]
  • Harrison SL, Lee AL, Elliott-Button HL, et al (2017) The role of pain in pulmonary rehabilitation: a qualitative study. Int J Chron Obstruct Pulmon Dis 12:3289–99 [CrossRef] [PubMed] [Google Scholar]
  • Janssen DJA, de Hosson SM, Bij de Vaate E, et al (2015) Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians. Chron Respir Dis 12:85–92 [CrossRef] [PubMed] [Google Scholar]
  • Schön D, Rosenkranz M, Regelsberger J, et al (2008) Reduced perception of dyspnea and pain after right insular cortex lesions. Am J Respir Crit Care Med 178:1173–9 [CrossRef] [PubMed] [Google Scholar]
  • Maignan M, Chauny JM, Daoust R, et al (2019) Pain during exacerbation of chronic obstructive pulmonary disease: a prospective cohort study. PLoS ONE doi.org/10.1371/journal.pone.0217370 [Google Scholar]
  • Divo M, Cote C, de Torres JP, et al (2012) Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186:155–61 [CrossRef] [PubMed] [Google Scholar]
  • Vozoris NT, Wang X, Fischer HD, et al (2016) Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J 48:683–93 [CrossRef] [PubMed] [Google Scholar]
  • Viglino D, Maignan M (2016) Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients. Eur Respir J 48:1817 [CrossRef] [PubMed] [Google Scholar]
  • Euceda G, Kong WT, Kapoor A, et al (2018) The effects of a comprehensive care management program on readmission rates after acute exacerbation of COPD at a community-based academic hospital. Chronic Obstr Pulm Dis 5:185–92 [Google Scholar]
  • Lane ND, Brewin K, Hartley TM, et al (2018) Specialist emergency care and COPD outcomes. BMJ Open Respir Res 5: e000334 [CrossRef] [PubMed] [Google Scholar]
  • Echevarria C, Steer J, Heslop-Marshall K, et al (2016) Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax 71:133–40 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.